Treatment of Genital Lichen Sclerosus in Girls Under 18 Years
Genital lichen sclerosus (LS) in female patients under 18 years requires a carefully considered treatment approach, as the characteristics of paediatric skin directly influence which agents are most appropriate and how they are used.
Clinical scenario
Female patient <18 years of age presenting with genital lichen sclerosus.
Treatment approach
Topical corticosteroid therapy — with agent selection informed by the particular vulnerabilities of paediatric skin — forms the basis of treatment for this population, used alongside a complementary topical measure.
Full regimen, sequencing, and dosing details are in the complete protocol →
Treatment goal
Suppression of signs and symptoms of lichen sclerosus
References
DOI: 10.1111/jdv.20083
- We recommend ultrapotent or potent topical corticosteroids in girls with genital lichen sclerosus.
- We recommend co-treatment with topical emollients in girls with genital lichen sclerosus.
- There are no comparative randomized trials in girls with LS; however, non-comparative studies show that treatment with potent to very potent topical steroids is effective in suppressing signs and symptoms of LS.
- In certain situations modern potent steroids may be preferred, namely in children because the skin is thinner and steroid related side effects may occur more frequently with ultrapotent steroids.
View source ↗